首页> 外文期刊>Biochemical Engineering Journal >Comparison of fetal bovine serum and human platelet lysate in cultivation and differentiation of dental pulp stem cells into hepatic lineage cells
【24h】

Comparison of fetal bovine serum and human platelet lysate in cultivation and differentiation of dental pulp stem cells into hepatic lineage cells

机译:胎牛血清和人血小板裂解物在牙髓干细胞培养和分化为肝谱系细胞中的比较

获取原文
获取原文并翻译 | 示例
           

摘要

The scarcity of organs for liver transplant is a major pressure point of liver transplantation. Hence, generating hepatocytes may provide an alternative choice for therapeutic applications. At present, dental pulp stem cell (SCDs) is an emerging source in regenerative medicine. However, existing protocols for cell culture requires fetal bovine serum (FBS) as a nutritional supplement and may carry the risk of transmitting diseases. Therefore, the present study was undertaken to examine the efficacy of human platelet lysate (HPL) as a substitute for FBS in terms of proliferation and differentiation of SCDs into hepatic lineage cells. The result showed that HPL had displayed a superior effect on the proliferation of SCDs. Next, we induced SCDs into hepatic lineage cells which thrived by initiation and followed by maturation into functional hepatocytes for a total of 21 days. We observed that the gene, protein and its functional profile during this differentiation process reiterated in vivo liver development demonstrating a steady down-regulation of early endoderm markers (GATA4, GATA6, SOX17, HNF4a, HNF3p and AFP) with the up-regulation of hepatic specific markers (TDO, TO, TAT, ALB, AAT, CK18). We also noticed the presence of CK19 suggesting a progenitor population. To ascertain this, we checked for the expression of pluripotent markers and observed that it remained unchanged throughout the experiment period. Our results provide new insights on the ability of SCDs to differentiate into hepatic lineage cells and most remarkably, this can be done in autologous settings whereby both cell source and HPL can be derived from the same donor thus reducing the risk of disease transmission.
机译:肝移植器官的缺乏是肝移植的主要压力点。因此,产生肝细胞可以为治疗应用提供替代选择。目前,牙髓干细胞(SCD)是再生医学的新兴来源。但是,现有的细胞培养方案需要胎牛血清(FBS)作为营养补充,并且可能带有传播疾病的风险。因此,本研究旨在从SCD增殖和分化为肝谱系细胞方面研究人血小板裂解物(HPL)替代FBS的功效。结果表明,HPL对SCD的增殖表现出优异的作用。接下来,我们将SCD诱导入肝谱系细胞,该细胞在开始时就繁盛,然后成熟为功能性肝细胞,共21天。我们观察到,在分化过程中的基因,蛋白质及其功能特征重申了体内肝脏的发展,表明早期内胚层标记物(GATA4,GATA6,SOX17,HNF4a,HNF3p和AFP)稳定下调,而肝细胞上调特定标记(TDO,TO,TAT,ALB,AAT,CK18)。我们还注意到CK19的存在提示了祖细胞。为了确定这一点,我们检查了多能标记的表达,并观察到在整个实验过程中它保持不变。我们的结果为SCD分化为肝谱系细胞的能力提供了新的见识,最显着的是,这可以在自体环境中完成,从而细胞来源和HPL都可以来自同一供体,从而降低了疾病传播的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号